Replies to post #29272 on OncoSec Medical Inc (ONCSQ)

[lasers]

Yes a former key Merck R&D scientist that has done multi-year research and Clinical Trials specifically for MK-3475 Keytruda would be a plus for any other Pharma that wants to promote Combos with Keytruda.

BTW BMS has sued Merck that Keytruda technicals infringe on BMS Patents.

http://www.wsj.com/articles/bristol-myers-ono-suing-merck-over-cancer-drug-patent-1410101449?tesla=y&mg=reno64-wsj&url=http://online.wsj.com/article/SB10001424052970203523604580139781945846338.html

[mybikeisorange]

trading.jeff,

I think it is the opposite. The fact that Merck obviously hands out Keytruda to anyone willing to try a combination trial negates the notion that ONCS is somehow special just because Pierce used to work for Merck. ONCS may have a good hypothesis for combining Immunopulse with Keytruda (I like that hypothesis as well or else I would not be invested/interested in this stock), but make no mistake, that did not make ONCS special to Merck. ONCS still has to prove it works, just like all of the other researchers that Merck has supplied Keytruda to.